Search This Blog

Thursday, May 7, 2026

Atara: updated ALLELE dataset with historical controls could support BLA resubmission

 

Atara: FDA agrees updated ALLELE dataset with historical controls could support Pierre Fabre tabelecleucel BLA resubmission

  • Decision followed a Type A meeting and outlines a clearer U.S. regulatory path for tabelecleucel.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)